SINOMAB BIO-B(03681),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03681 SINOMAB BIO-B

Closed 10-29 15:59:14

1.020

-0.050

-4.67%

High1.050	Low1.010	Vol359.70K
Open1.050	D1 Closing1.070	Amplitude3.74%
Mkt Cap1.41B	Tradable Cap1.41B	Total Shares1.39B
T/O366.19K	T/O Rate0.03%	Tradable Shares1.39B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03681","market":"HK","secType":"STK","nameCN":"SINOMAB BIO-B","latestPrice":1.02,"timestamp":1793260754389,"preClose":1.07,"halted":0,"volume":359700,"delay":0,"changeRate":-0.04672897196261686,"floatShares":1387000000,"shares":1387000000,"eps":-0.085548,"marketStatus":"Closed","change":-0.05,"latestTime":"10-29 15:59:14","open":1.05,"high":1.05,"low":1.01,"amount":366186,"amplitude":0.037383,"askPrice":1.05,"askSize":27000,"bidPrice":1.02,"bidSize":1800,"shortable":0,"etf":0,"ttmEps":-0.154444,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1793323800000},"marketStatusCode":5,"adr":0,"listingDate":1573488000000,"exchange":"SEHK","adjPreClose":1.07,"openAndCloseTimeList":[[1793237400000,1793246400000],[1793250000000,1793260800000]],"volumeRatio":1.228987,"lotSize":300,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03681","defaultTab":"news","newsList":[{"id":"2674836010","title":"Asian Market Insights: Autostreets Development And 2 Other Promising Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2674836010","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674836010?lang=en_us&edition=fundamental","pubTime":"2026-10-09 12:04","pubTimestamp":1791518688,"startTime":"0","endTime":"0","summary":"Amidst a backdrop of mixed signals from global markets, the Asian stock landscape continues to capture investor attention with its unique blend of challenges and opportunities. As investors navigate this complex environment, penny stocks—though often considered relics of past market eras—remain relevant due to their potential for growth and value. These smaller or newer companies can offer compelling opportunities, especially when backed by strong financials, making them intriguing candidates...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2055000-choice2-card/1788949255437","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2055000-choice2-card/1788949255437"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/cn/materials/shse-600725/yunnan-yunwei-shares/news/asian-market-insights-autostreets-development-and-2-other-pr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/cn/materials/shse-600725/yunnan-yunwei-shares/news/asian-market-insights-autostreets-development-and-2-other-pr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["03681","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134537143","title":"Sinomab Bio: Issued Share Capital Steady in September; 6.93 Million Share Options Lapse","url":"https://stock-news.laohu8.com/highlight/detail?id=1134537143","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134537143?lang=en_us&edition=fundamental","pubTime":"2026-10-07 16:42","pubTimestamp":1791362542,"startTime":"0","endTime":"0","summary":"Sinomab Bio (SINOMAB BIOSCIENCE LIMITED) filed its Monthly Return for Equity Issuer for the period ended 30 September 2026, confirming that no changes occurred in its issued share capital during the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192416179","title":"SinoMab (SinoMab BioScience) 1H 2026: Net Loss Deepens to RMB127.39 Million Amid Pipeline Push and Asset-Light Shift","url":"https://stock-news.laohu8.com/highlight/detail?id=1192416179","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192416179?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:06","pubTimestamp":1790586399,"startTime":"0","endTime":"0","summary":"SinoMab BioScience released its unaudited interim results for the six months ended 30 June 2026, detailing a larger half-year loss alongside significant clinical progress and an ongoing transition to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"SinoMab (SinoMab BioScience) 1H 2026: Net Loss Deepens to RMB127.39 Million Amid Pipeline Push and Asset-Light Shift","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169372373","title":"SinoMab BioScience Announces Release of 2026 Interim Report and Shifts to Full Electronic Distribution","url":"https://stock-news.laohu8.com/highlight/detail?id=1169372373","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169372373?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:04","pubTimestamp":1790586251,"startTime":"0","endTime":"0","summary":"SinoMab BioScience Limited has published its Interim Report 2026 in both English and Chinese on the HKExnews website and on the company’s own site. Printed copies are available free of charge upon...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152189014","title":"SinoMab Shareholders Unanimously Endorse Asset Disposal at 7 Sep 2026 EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1152189014","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152189014?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:44","pubTimestamp":1788774285,"startTime":"0","endTime":"0","summary":"SinoMab BioScience Limited reported that its extraordinary general meeting held on 7 September 2026 approved the proposed disposal under the Sale and Purchase Agreement with full shareholder support....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665200318","title":"SinoMab BioScience Held Shareholder Meeting, Disposal Resolution Drew 100% Support","url":"https://stock-news.laohu8.com/highlight/detail?id=2665200318","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665200318?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:07","pubTimestamp":1788772023,"startTime":"0","endTime":"0","summary":"SinoMab BioScience held shareholder meeting, disposal resolution drew 100% supportSinoMab BioScience held an extraordinary general meeting on Sept. 7, 2026.Shareholders adopted a resolution to confirm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL9Tlkd2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","03681","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881007","title":"Sinomab Bioscience Posts HY Loss of Rmb127.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881007","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881007?lang=en_us&edition=fundamental","pubTime":"2026-09-01 00:52","pubTimestamp":1788195169,"startTime":"0","endTime":"0","summary":"BRIEF-Sinomab Bioscience Posts HY Loss Of RMB127.4 MillionAug 31 (Reuters)-SinoMab BioScience Ltd3681.HK:HY LOSS RMB127.4 MILLIONFurther company coverage:3681.HK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0D9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115010924","title":"SinoMab BioScience H1 2026: Wider Loss on R&D Push, Cash Falls to RMB196.45 Million, SM17 Enters Phase 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1115010924","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115010924?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:05","pubTimestamp":1788188749,"startTime":"0","endTime":"0","summary":"SinoMab BioScience Limited released unaudited results for the six months ended 30 June 2026, highlighting an intensified clinical pipeline drive alongside a deliberate shift to an asset-light model....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"SinoMab BioScience H1 2026: Wider Loss on R&D Push, Cash Falls to RMB196.45 Million, SM17 Enters Phase 2","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663001896","title":"SinoMab BioScience Ltd - Hy Loss Rmb127.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663001896","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663001896?lang=en_us&edition=fundamental","pubTime":"2026-08-31 22:27","pubTimestamp":1788186426,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0D9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03681","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663001857","title":"SinoMab FY26 H1 Loss Widens to RMB 127.4 Million; Funding Available Drops to RMB 196.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663001857","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663001857?lang=en_us&edition=fundamental","pubTime":"2026-08-31 22:25","pubTimestamp":1788186341,"startTime":"0","endTime":"0","summary":"SinoMab FY26 H1 loss widens to RMB 127.4 million; funding available drops to RMB 196.5 millionSinoMab posted a net loss of RMB 127.4 million for the six months ended June 30, 2026, versus RMB 49.8 mil","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL5rZnp2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116902156","title":"SinoMab BioScience to Divest Suzhou Plant for RMB 280 Million; Aims to Cut Debt, Refocus on R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=1116902156","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116902156?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:45","pubTimestamp":1787265951,"startTime":"0","endTime":"0","summary":"SinoMab BioScience Limited (SinoMab, HKEX: 03681) has agreed to sell its Suzhou Industrial Park land and biopharmaceutical manufacturing facility to Suzhou Yigong Pinyuan Biopharmaceutical, a wholly...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105636128","title":"SinoMab BioScience Calls 7 Sep 2026 EGM to Approve RMB 280.00 Million Suzhou Asset Disposal","url":"https://stock-news.laohu8.com/highlight/detail?id=1105636128","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105636128?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:45","pubTimestamp":1787265946,"startTime":"0","endTime":"0","summary":"SinoMab BioScience Limited has issued a notice convening an Extraordinary General Meeting (EGM) on 7 September 2026 at 10:00 a.m. in Central, Hong Kong. The sole agenda item seeks shareholder...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661230661","title":"SinoMab BioScience Announces Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2661230661","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661230661?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:07","pubTimestamp":1787263657,"startTime":"0","endTime":"0","summary":"SinoMab BioScience announces extraordinary general meetingSinoMab BioScience will hold an extraordinary general meeting in Central, Hong Kong on Sept. 7, 2026.Shareholders will vote on the proposed di","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDLbFrYsr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660447344","title":"SinoMab BioScience Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660447344","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660447344?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:04","pubTimestamp":1787137487,"startTime":"0","endTime":"0","summary":"SinoMab BioScience schedules board meeting to review interim resultsSinoMab BioScience set a board meeting for Aug. 31, 2026 to review the group’s interim results for the six months ended June 30, 202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL4cbBb6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","03681","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131006605","title":"SinoMab Schedules 7 Sep 2026 EGM and Announces Book-Closure Window for Suzhou Property Disposal","url":"https://stock-news.laohu8.com/highlight/detail?id=1131006605","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131006605?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:07","pubTimestamp":1787058451,"startTime":"0","endTime":"0","summary":"SinoMab BioScience Limited has fixed 10:00 a.m. on Monday, 7 September 2026 for an Extraordinary General Meeting (EGM) in Room 3, 14/F, Fairmont House, 8 Cotton Tree Drive, Central, Hong Kong. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660460819","title":"SinoMab BioScience Sets Sept. 7 Shareholder Vote on Proposed Suzhou Property, Facility Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2660460819","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660460819?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:05","pubTimestamp":1787058303,"startTime":"0","endTime":"0","summary":"SinoMab BioScience sets Sept. 7 shareholder vote on proposed Suzhou property, facility saleSinoMab BioScience set a 7 September 2026 extraordinary general meeting to vote on its proposed disposal of a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL5MmPCG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184290740","title":"SinoMab Announces Resignation of Executive Director and COO Fang Liang","url":"https://stock-news.laohu8.com/highlight/detail?id=1184290740","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184290740?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:47","pubTimestamp":1787050030,"startTime":"0","endTime":"0","summary":"SinoMab BioScience Limited has reported that Ms. Fang Liang resigned from her roles as executive director and chief operating officer, effective 18 August 2026. The company cites her decision to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660469023","title":"SinoMab BioScience Files List of Directors, Board Committee Memberships and Disclosure-Responsible Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2660469023","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660469023?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:45","pubTimestamp":1787049913,"startTime":"0","endTime":"0","summary":"SinoMab BioScience files list of directors, board committee memberships and disclosure-responsible managementSinoMab BioScience listed its board and committee memberships as of Aug. 18, 2026.Executive","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL5bw6Cr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","03681","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660777469","title":"SinoMab BioScience - Fang Liang Resigns as Executive Director and COO Effective 18 August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660777469","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660777469?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:43","pubTimestamp":1787049838,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F0A6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03681","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140566361","title":"SinoMab Announces Second Postponement of Circular for Suzhou Property Disposal, New Deadline Set for 21 August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1140566361","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140566361?lang=en_us&edition=fundamental","pubTime":"2026-08-10 17:48","pubTimestamp":1786355304,"startTime":"0","endTime":"0","summary":"SinoMab BioScience Limited has delayed the release of its shareholder circular for a major transaction involving the disposal of its Suzhou property and facility. The company previously scheduled...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinomab.com","stockEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":0.049},{"period":"3month","weight":-0.2132},{"period":"6month","weight":-0.2867},{"period":"1year","weight":-0.3476},{"period":"ytd","weight":-0.2015}],"compareEarnings":[{"period":"1week","weight":-0.0236},{"period":"1month","weight":-0.0628},{"period":"3month","weight":-0.1069},{"period":"6month","weight":-0.104},{"period":"1year","weight":-0.1234},{"period":"ytd","weight":-0.0989}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"SinoMab BioScience Ltd is a Hong Kong-based biopharmaceutical company mainly dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company primarily develops mAb-based biologics and new chemical entities (NCE) and its product SM03 is a mAb for the treatment of rheumatoid arthritis (RA). The Company is also developing drugs such as SM17, which has the potential to treat atopic dermatitis (AD), asthma, idiopathic pulmonary fibrosis (IPF) and other immune diseases, and SN1011, which targets systemic lupus erythematosus (SLE), pemphigus, multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD).","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.001496},{"month":2,"riseRate":0.428571,"avgChangeRate":0.047286},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.044577},{"month":4,"riseRate":0.714286,"avgChangeRate":0.048474},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.024206},{"month":6,"riseRate":0.285714,"avgChangeRate":0.017188},{"month":7,"riseRate":0.428571,"avgChangeRate":0.073842},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.147299},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.054355},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.051024},{"month":11,"riseRate":0.666667,"avgChangeRate":-0.003752},{"month":12,"riseRate":0.428571,"avgChangeRate":0.081979}],"exchange":"SEHK","name":"SINOMAB BIO-B","nameEN":"SINOMAB BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SINOMAB BIO-B(03681),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SINOMAB BIO-B(03681) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SINOMAB BIO-B,03681,SINOMAB BIO-B股票,SINOMAB BIO-B股票老虎,SINOMAB BIO-B股票老虎国际,SINOMAB BIO-B行情,SINOMAB BIO-B股票行情,SINOMAB BIO-B股价,SINOMAB BIO-B股市,SINOMAB BIO-B股票价格,SINOMAB BIO-B股票交易,SINOMAB BIO-B股票购买,SINOMAB BIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SINOMAB BIO-B(03681),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SINOMAB BIO-B(03681) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}